Word: molecular
(lookup in dictionary)
(lookup stats)
Dates: during 1970-1979
Sort By: most recent first
(reverse)
...group on Thursday, Nov. 15, at 8 p.m. in the Geology Lecture Hall. This forum, entitled "Biology as a Social Weapon," will also deal with the close parallels between sociobiology and previous historical attempts to "naturalize" social inequality. Joseph Alper '63 University of Massachusetts, Boston Jonathan Beckwith '57 and Molecular Genetics Edward Egelman for the Sociobiology Study Group...
...recent study by Harvard researchers on genetic growth patterns has revealed how carcinogens destroy cells inhabited by a virus. Mark S. Ptashne, professor of Biochemistry and Molecular Biology, explained the mechanism by which the phage lambda, a parasitical virus, grows relentlessly when exposed to cancer-causing agents and eventually destroys its host cell, Ptashne said yesterday...
...unit in question was originally owned by Arthur Drinkwater '00, for many years the oldest living Harvard alumnus. Drinkwater died recently, leaving the unit to Harvard, which sold it to Stephen Harrison, Professor of Biochemistry and Molecular Biology. The University bought the condo from Harrison last month...
...Mark Ptashne, 39. In 1967 the Harvard molecular biologist detected a molecule, called a "represser," that regulates the way a gene functions, possibly a key in the study of cancer. Ptashne was majoring in philosophy at Reed College in Portland, Ore., when he became fascinated by a theory about represser molecules and switched to chemistry in his senior year. During the Viet Nam War, Ptashne was deeply involved in antiwar politics at Harvard and went to the extent of lecturing at the University of Hanoi. But he became disillusioned with leftist politics in 1976 when some radicals and others tried...
...colleagues, Ian Creese and Dr. Larry Tune, have developed a simple blood test that should be especially useful in treating the nation's estimated 2 million to 5 million schizophrenics. Already tested on 30 patients, it is based on pioneering studies of the brain's receptors, or molecular sites to which its own drug-like chemicals bind-almost as if they were keys in a lock. A blood sample from a patient is added to a tube containing animal brain tissue and a radioactively tagged chemical known to bind to particular receptors. Whatever drug is in the patient...